Total Funding: 32000000.0
Headquarters: New York, New York, United States
Funding Status: Early Stage Venture
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Last Funding Type: Series A
Last Funding Date: 2022-07-28
Investors Number: 8.0
Founded Date: 2020-01-01
Industry: Early Drug Development